ARMISTICE CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001601086

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q3 2026 · 335 positions · Total reported value $7.32B · Top-10 concentration 68.7% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 80.3% · 158 new · 82 cut · 148 exited

Active Share (vs S&P 500): 94.8% · vs QQQ: 95.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.0% · vs SPY -4.1% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.3% · vs SPY -1.9% · Latest Value $7.32B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, ARMISTICE CAPITAL, LLC disclosed 335 equity positions with a combined reported value of $7.32B. The filing implies a focused portfolio: its ten largest positions account for 68.7% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q3 2026 were SPY ($2.55B), IWM ($1.83B), SUPN ($109.67M). By sector, the heaviest allocations are Health Care 26.1%, Technology 6.7%. Versus the prior quarter, allocation shifted toward Other (+5.5pp) and away from Technology (-0.6pp), Industrials (-1.3pp).

Versus the prior quarter, ARMISTICE CAPITAL, LLC opened 158 new positions, trimmed 82 and fully exited 148, a turnover rate of 80.3% of positions. The portfolio's overlap with the prior quarter was 37% of names.

The largest new positions opened in Q3 2026 were TLX ($18.32M), GEHC ($16.30M), BNTX ($16.12M).

Of the 148 positions fully exited versus the prior quarter, the largest were HUM ($28.81M), ILMN ($16.02M), PBH ($15.88M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • TLX TELIX PHARMACEUTICAL LTD · $18.32M
  • GEHC GE HEALTHCARE TECHNOLOGIES I · $16.30M
  • BNTX BIONTECH SE · $16.12M
  • SPSC SPS COMM INC · $15.73M
  • DKS DICKS SPORTING GOODS INC · $13.07M
  • LION LIONSGATE STUDIOS CORP · $8.27M
  • MBC MASTERBRAND INC · $7.25M
  • XMTR XOMETRY INC · $5.52M

Fully Exited (vs previous quarter)

  • HUM HUMANA INC · prev qtr: $28.81M
  • ILMN ILLUMINA INC · prev qtr: $16.02M
  • PBH PRESTIGE CONSMR HEALTHCARE I · prev qtr: $15.88M
  • FWONK LIBERTY MEDIA CORP DEL · prev qtr: $15.71M
  • ITGR INTEGER HLDGS CORP · prev qtr: $15.68M
  • LYV LIVE NATION ENTERTAINMENT IN · prev qtr: $14.98M
  • NVO NOVO-NORDISK A S · prev qtr: $14.96M
  • TWST TWIST BIOSCIENCE CORP · prev qtr: $14.61M

Insider Transactions (Form 4)

Latest ARMISTICE CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Armistice Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 325 US equity positions with a combined value of $7.59B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-100464 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $4.72B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: armisticecapital.com

Portfolio Structure

  • 325 positions · $7.59B reported value (Q2 2026)
  • Top 10 holdings = 65.2% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 31.5%
  • Average position size: $23.35M

Sector Tilt

  • Health Care 29.3%
  • Information Technology 7.4%
  • Consumer Discretionary 5.2%
  • (classified holdings cover 45% of value)

Quarterly Activity

  • Q2 2026: 168 new, 72 added, 65 reduced, 96 exited
  • 20 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: Aggressive bullish tilt, with significant additions to large-cap U.S. equity ETFs (SPY, IWM), suggesting strong confidence in broad market upside. 2. Key moves: - Added: SPY (+4.7% shares), IWM (+13.8% shares), AGIO (+7.4% shares), PTCT (+96.6% shares), IRWD (+7.7% shares). - Reduced: SUPN (-3.7% shares), CYTK (-1.8% shares), RIGL (-8.1% shares), INCY (-33.3% shares), NBIX (-6.7% shares). 3. Portfolio structure: Passive-heavy (SPY/IWM dominate), biotech/Health Care overweight (6/10 top holdings), high risk appetite (concentrated positions, volatile biotech bets). 4. Per-holding one-liner: - SPY: S&P 500 ETF (U.S. large-cap equities). - IWM: Russell 2000 ETF (U.S. small-cap equities). - SUPN: Neurology-focused pharma (unverified). - AGIO: Cancer metabolism drugs (unverified). - PTCT: Rare disease therapeutics (unverified). - CYTK: Cardiovascular muscle drugs (unverified). - RIGL: Autoimmune disease treatments (unverified). - INCY: Oncology/immunology drugs (unverified). - NBIX: Neuroendocrine therapies (unverified). - IRWD: GI motility drugs (unverified). 5. Style summary: Aggressive, market-cap-weighted U.S. equity exposure with concentrated biotech bets, favoring large-caps and selectively adding high-conviction healthcare names.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 03:59

Sector Allocation

Health Care 26.1%
Technology 6.7%
Energy 0.1%
Financials 0.1%
Other 60.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.35M $2.55B 34.91%
34.91%
Add
2 6.60M $1.83B 25.07%
25.07%
Add
3 2.55M $109.67M 1.50%
1.50%
Reduce
4 2.58M $85.72M 1.17%
1.17%
Add
5 1.30M $84.05M 1.15%
1.15%
Add
6 1.18M $77.79M 1.06%
1.06%
Reduce
7 1.54M $73.96M 1.01%
1.01%
Reduce
8 600.04K $72.82M 0.99%
0.99%
Reduce
9 500.00K $70.92M 0.97%
0.97%
Reduce
10 15.00M $59.55M 0.81%
0.81%
Add
11 1.44M $56.38M 0.77%
0.77%
Reduce
12 1.62M $54.89M 0.75%
0.75%
Add
13 888.69K $51.15M 0.70%
0.70%
Reduce
14 92.02K $46.38M 0.63%
0.63%
Reduce
15 185.83K $46.30M 0.63%
0.63%
Reduce
16 5.72M $46.08M 0.63%
0.63%
Reduce
17 2.68M $43.14M 0.59%
0.59%
Reduce
18 56.74K $43.02M 0.59%
0.59%
Reduce
19 720.00K $42.39M 0.58%
0.58%
Add
20 700.00K $42.38M 0.58%
0.58%
Reduce
21 1.60M $40.21M 0.55%
0.55%
Add
22 108.34K $37.77M 0.52%
0.52%
Reduce
23 724.00K $34.88M 0.48%
0.48%
Add
24 1.14M $34.41M 0.47%
0.47%
Reduce
25 83.89K $34.11M 0.47%
0.47%
Add
26 3.62M $34.10M 0.47%
0.47%
Add
27 824.00K $33.97M 0.46%
0.46%
Reduce
28 486.65K $33.34M 0.46%
0.46%
Reduce
29 64.66K $33.16M 0.45%
0.45%
Reduce
30 90.00K $33.04M 0.45%
0.45%
Reduce
31 500.00K $32.73M 0.45%
0.45%
Add
32 95.00K $32.69M 0.45%
0.45%
Reduce
33 4.50M $32.51M 0.44%
0.44%
Add
34 660.70K $31.22M 0.43%
0.43%
Add
35 876.00K $29.79M 0.41%
0.41%
Reduce
36 692.00K $29.01M 0.40%
0.40%
Reduce
37 3.24M $28.67M 0.39%
0.39%
Reduce
38 2.36M $28.51M 0.39%
0.39%
Add
39 357.04K $28.36M 0.39%
0.39%
Add
40 6.36M $28.26M 0.39%
0.39%
Hold
41 1.95M $27.90M 0.38%
0.38%
Reduce
42 250.00K $26.89M 0.37%
0.37%
Add
43 13.75M $26.68M 0.36%
0.36%
Reduce
44 177.70K $25.83M 0.35%
0.35%
Reduce
45 120.18K $24.64M 0.34%
0.34%
Reduce
46 1.54M $23.62M 0.32%
0.32%
Reduce
47 6.00M $23.16M 0.32%
0.32%
Add
48 160.00K $22.79M 0.31%
0.31%
Add
49 2.10M $22.45M 0.31%
0.31%
Reduce
50 31.99K $21.59M 0.29%
0.29%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 74% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 74% · recall 74% · F1 74% · avg rank error 1.8 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% SPY · IWM · PTCT · ARGX · NBIX · SUPN · AUPH · GSK · SWAV · JAZZ SPY · IWM · PTCT · NBIX · INCY · SUPN · ARGX · DCPH · AGIO · IMVT
2024-Q2 90% 90% 90% IWM · SPY · PTCT · INCY · NBIX · ARGX · SUPN · DCPH · AGIO · IMVT SPY · IWM · PTCT · SUPN · NBIX · INCY · IMVT · AGIO · ARGX · NVO
2024-Q3 70% 70% 70% SPY · IWM · PTCT · SUPN · NBIX · INCY · IMVT · AGIO · ARGX · NVO IWM · SPY · PTCT · SUPN · INCY · TVTX · CYTK · AGIO · GRFS · ARGX
2024-Q4 60% 60% 60% SPY · IWM · PTCT · SUPN · INCY · CYTK · TVTX · AGIO · GRFS · NARI IWM · SPY · PTCT · SUPN · TVTX · INCY · NBIX · EXAS · VRTX · ICLR
2025-Q1 80% 80% 80% IWM · SPY · PTCT · SUPN · NBIX · TVTX · INCY · VRTX · EXAS · GSK SPY · IWM · PTCT · SUPN · TVTX · NBIX · INCY · EXAS · REGN · GRFS
2025-Q2 70% 70% 70% SPY · IWM · PTCT · SUPN · TVTX · NBIX · INCY · REGN · EXAS · FRPT SPY · IWM · PTCT · SUPN · TVTX · INCY · NBIX · IMVT · GRFS · GEHC
2025-Q3 80% 80% 80% IWM · SPY · PTCT · SUPN · TVTX · IMVT · INCY · NBIX · GRFS · GEHC IWM · SPY · PTCT · TVTX · SUPN · CYTK · MDGL · INCY · NBIX · IMVT
2025-Q4 80% 80% 80% IWM · SPY · PTCT · TVTX · CYTK · MDGL · SUPN · IMVT · INCY · NBIX SPY · IWM · PTCT · MDGL · TVTX · SUPN · NBIX · INCY · AMZN · XRAY
2026-Q1 80% 80% 80% SPY · IWM · PTCT · MDGL · TVTX · SUPN · NBIX · INCY · XRAY · AGIO SPY · IWM · TVTX · MDGL · SUPN · NBIX · AGIO · FRPT · INCY · DYN
2026-Q2 80% 80% 80% SPY · IWM · TVTX · MDGL · AGIO · NBIX · SUPN · FRPT · INCY · DYN SPY · IWM · MDGL · SUPN · CYTK · INCY · NBIX · AGIO · UNH · FRPT
2026-Q3 ★ 70% 70% 70% SPY · IWM · MDGL · SUPN · CYTK · INCY · NBIX · AGIO · UNH · FRPT SPY · IWM · SUPN · AGIO · PTCT · CYTK · RIGL · INCY · NBIX · IRWD

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings90 Model coverage99.4%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+1.04%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+18.05%vs benchmark
Barra annualised vol27.0%Model estimate
Realised vol5.0%Annualised in window
Weighted beta1.11Raw exposure
Factor / specific risk88% / 12%Share of variance
Top-10 concentration89.4%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16ARMISTICE CAPITAL, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+1.04%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+18.05%Portfolio − benchmark
Arithmetic return sum+1.05%Difference vs compounded is the cross term
Weighted raw beta1.11Weighted holding betas
Realised volatility (annualised)4.99%Daily returns in window
Barra model volatility (annualised)27.04%Factor + specific
Factor share of variance87.6%Barra factors
Specific share of variance12.4%Stock residuals
Reported value$5.28B13F long US equity

2. Return attribution

The +1.05% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.94% -185.0%
Momentum & Growth 3 +0.07% 6.8%
Volatility & Tail Risk 7 +2.17% 207.6%
Industry 12 +7.66% 730.6%
Specific 1 -6.92% -660.0%
Return attribution (style + industry, %)-12.5-6.2+0.0+6.2+12.5Health Care+0.42Mid Cap-0.44Amihud Illiquidity-0.79Skewness-0.90Leverage (Downside Vol)+1.08Beta+1.15Max Drawdown-1.63Turnover+1.71Non-linear Size+2.18Kurtosis-3.73Size-4.39Residual Volatility-5.36Other+7.30Historical Volatility+11.57
Factor Type Exposure Factor return Contribution Share of |return|
Historical Volatility Style -0.83 -14.00% +11.57% 1104.4%
Other Industry +0.83 +8.78% +7.30% 696.5%
Non-linear Size Style +2.16 +1.01% +2.18% 208.3%
Turnover Style -0.36 -4.80% +1.71% 163.0%
Beta Style +0.26 +4.44% +1.15% 109.6%
Leverage (Downside Vol) Style -0.63 -1.71% +1.08% 103.0%
Health Care Industry +0.06 +6.98% +0.42% 40.1%
Consumer Discretionary Industry +0.03 +6.71% +0.23% 22.1%
Growth Style +0.08 +1.75% +0.14% 13.3%
Short-term Reversal Style -0.06 +0.87% -0.05% -5.1%
Liquidity Style -0.59 +0.36% -0.21% -19.9%
Information Technology Industry +0.06 -5.13% -0.32% -30.2%
Mid Cap Style +0.23 -1.94% -0.44% -42.1%
Amihud Illiquidity Style +1.77 -0.45% -0.79% -75.3%
Skewness Style +0.20 -4.39% -0.90% -85.8%
Max Drawdown Style +0.93 -1.76% -1.63% -155.9%
Kurtosis Style -0.50 +7.51% -3.73% -356.4%
Size Style +2.25 -1.95% -4.39% -418.9%
Residual Volatility Style -1.63 +3.29% -5.36% -511.4%
Specific Specific — — -6.92% -660.0%

3. Risk attribution

Annualised volatility is 27.04%; factor risk explains 87.6% of variance and specific risk 12.4%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-67.3-33.7+0.0+33.7+67.3Max Drawdown-2.16Skewness-0.66Consumer Discretionary+0.60Kurtosis+0.87Historical Volatility+1.15Health Care+1.32Non-linear Size+1.89Amihud Illiquidity+2.90Beta+3.86Size+4.07Leverage (Downside Vol)+5.19Residual Volatility+6.42Specific+12.40Other+62.36
Factor Type Exposure Share of variance Vol contribution Share of vol
Other Industry +0.83 62.4% +16.86% 16.9%
Specific Specific — 12.4% +3.35% 3.4%
Residual Volatility Style -1.63 6.4% +1.74% 1.7%
Leverage (Downside Vol) Style -0.63 5.2% +1.40% 1.4%
Size Style +2.25 4.1% +1.10% 1.1%
Beta Style +0.26 3.9% +1.04% 1.0%
Amihud Illiquidity Style +1.77 2.9% +0.78% 0.8%
Non-linear Size Style +2.16 1.9% +0.51% 0.5%
Health Care Industry +0.06 1.3% +0.36% 0.4%
Historical Volatility Style -0.83 1.1% +0.31% 0.3%
Kurtosis Style -0.50 0.9% +0.24% 0.2%
Consumer Discretionary Industry +0.03 0.6% +0.16% 0.2%
Information Technology Industry +0.06 0.3% +0.08% 0.1%
Industrials Industry +0.01 0.2% +0.06% 0.1%
Liquidity Style -0.59 -0.2% -0.06% -0.1%
Turnover Style -0.36 -0.5% -0.14% -0.1%
Skewness Style +0.20 -0.7% -0.18% -0.2%
Max Drawdown Style +0.93 -2.2% -0.58% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-2.0-0.90.31.52.6Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size +2.25 +2.10 +0.15
Non-linear Size +2.16 +1.68 +0.49
Mid Cap +0.23 +0.13 +0.10
Beta +0.26 +1.29 -1.04
Momentum +0.00 +0.72 -0.71
Short-term Reversal -0.06 -0.64 +0.58
Residual Volatility -1.63 -0.40 -1.23
Historical Volatility -0.83 +0.86 -1.69
Liquidity -0.58 +0.11 -0.70
Amihud Illiquidity +1.77 +1.16 +0.61
Turnover -0.36 +0.21 -0.56
Growth +0.08 +0.58 -0.50
Leverage (Downside Vol) -0.63 +0.14 -0.77
Skewness +0.20 +0.24 -0.03
Kurtosis -0.50 +0.21 -0.71
Max Drawdown +0.93 -0.08 +1.01

5. Industry allocation & Brinson

Industry allocation (weight, %)-8.316.641.566.591.4Communication ServicesConsumer StaplesUtilitiesIndustrialsConsumer DiscretionaryHealth CareInformation TechnologyOtherPortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 6.2% 73.6% -14.13% -22.33% +3.51% +6.04% -5.54% +15.57%
Other 83.1% 0.0% +1.77% +0.00% +14.23% +0.00% +1.47% +1.47%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Health Care 6.0% 1.7% +8.36% +8.29% +1.09% +0.00% +0.00% +0.36%
Utilities 0.1% 0.8% -7.25% +11.13% -0.20% -0.14% +0.13% -0.09%
Consumer Staples 0.1% 0.8% +16.10% +15.26% -0.25% +0.01% -0.01% -0.12%
Consumer Discretionary 3.4% 8.8% +4.73% +3.76% -1.12% +0.09% -0.05% -0.17%
Industrials 0.9% 11.1% -6.75% +4.36% -2.19% -1.23% +1.13% -0.55%
Total +15.00% +5.15% -3.33% +16.82%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
SPY STATE STR SPDR S&P 500 ETF T Other 48.35% +2.16% +1.04% Add
IWM ISHARES TR Other 34.71% +1.24% +0.43% Add
IRWD IRONWOOD PHARMACEUTICALS INC Health Care 1.13% +22.17% +0.25% Add
MDGL MADRIGAL PHARMACEUTICALS INC Health Care 0.88% -15.87% -0.14% Reduce
AMZN AMAZON COM INC Consumer Discretionary 0.88% +3.45% +0.03% Reduce
REGN REGENERON PHARMACEUTICALS Health Care 0.81% +25.60% +0.21% Reduce
MDB MONGODB INC Information Technology 0.71% -9.09% -0.07% Reduce
ISRG INTUITIVE SURGICAL INC Health Care 0.65% +7.65% +0.05% Add
UBER UBER TECHNOLOGIES INC Consumer Discretionary 0.63% +2.16% +0.01% Reduce
MSFT MICROSOFT CORP Information Technology 0.63% +0.99% +0.01% Reduce
UNH UNITEDHEALTH GROUP INC Health Care 0.62% +12.24% +0.08% Reduce
GOOGL ALPHABET INC Information Technology 0.62% -17.54% -0.11% Reduce
GTLB GITLAB INC Information Technology 0.59% +0.17% +0.00% Add
NTLA INTELLIA THERAPEUTICS INC Health Care 0.54% -18.24% -0.10% Add
BABA ALIBABA GROUP HLDG LTD Consumer Discretionary 0.51% -15.73% -0.08% Add
ALGN ALIGN TECHNOLOGY INC Health Care 0.49% +14.19% +0.07% Reduce
RDDT REDDIT INC Information Technology 0.43% -34.80% -0.15% Add
TMO THERMO FISHER SCIENTIFIC INC Industrials 0.41% +2.41% +0.01% Reduce
SRRK SCHOLAR ROCK HLDG CORP Health Care 0.35% -7.82% -0.03% Add
TSM TAIWAN SEMICONDUCTOR MANUFAC Information Technology 0.32% -18.14% -0.06% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 SPY Other 48.35% +2.16% +1.04%
2 IWM Other 34.71% +1.24% +0.43%
3 IRWD Health Care 1.13% +22.17% +0.25%
4 REGN Health Care 0.81% +25.60% +0.21%
5 CROX Consumer Discretionary 0.29% +36.40% +0.10%
6 GEHC Health Care 0.31% +26.91% +0.08%
7 UNH Health Care 0.62% +12.24% +0.08%
8 APP Information Technology 0.17% +42.97% +0.07%
9 INTC Information Technology 0.19% -53.86% -0.10%
10 GOOGL Information Technology 0.62% -17.54% -0.11%
11 MDGL Health Care 0.88% -15.87% -0.14%
12 NBIS Information Technology 0.27% -54.58% -0.15%
13 RDDT Information Technology 0.43% -34.80% -0.15%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +1.04%, versus -17.01% for the QQQ synthetic benchmark — an excess of +18.05%.
  2. Return attribution: the largest positive style/industry contributions came from Historical Volatility +11.57%, Other +7.30%, Non-linear Size +2.18%; the largest drags came from Residual Volatility -5.36%, Size -4.39%, Kurtosis -3.73%. Specific (stock-level) return contributed -6.91%.
  3. Risk attribution: Barra model volatility is 27.04% annualised; factor risk explains 88% of variance and specific risk 12%. The largest factor risk sources are Other 62.4%, Residual Volatility 6.4%, Leverage (Downside Vol) 5.2%.
  4. Style tilt: size +2.25, momentum +0.00, volatility -0.83, liquidity -0.58; the weighted raw beta is 1.11. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Other (+83.1 pp), the largest underweight is Information Technology (-67.5 pp). Allocation contributed +15.00%, selection +5.15% and interaction -3.33%.
  6. Concentration: the top-10 positions are 89.4% of the attributed portfolio and the model covers 99.4% of its value with full style exposures; the remainder is mapped to its sector only. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did ARMISTICE CAPITAL, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, ARMISTICE CAPITAL, LLC reported 335 equity positions worth $7.32B in aggregate; its largest disclosed positions were SPY ($2.55B), IWM ($1.83B), SUPN ($109.67M).

How large is ARMISTICE CAPITAL, LLC's portfolio?

ARMISTICE CAPITAL, LLC reported $7.32B of long equity holdings across 335 positions as of 2026-Q3. Top-10 holdings account for 68.7% of reported value.

What is ARMISTICE CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/armistice-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →